Ritonavir contraindications: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(One intermediate revision by the same user not shown)
Line 5: Line 5:
==Contraindications==
==Contraindications==


*When co-administering NORVIR with other protease inhibitors, see the full prescribing information for that protease inhibitor including contraindication information.
*When co-administering NORVIR with other [[protease inhibitors]], see the full prescribing information for that protease inhibitor including contraindication information.
*NORVIR is contraindicated in patients with known hypersensitivity (e.g., [[toxic epidermal necrolysis]] (TEN) or [[Stevens-Johnson syndrome]]) to ritonavir or any of its ingredients.
*NORVIR is contraindicated in patients with known hypersensitivity (e.g., [[toxic epidermal necrolysis]] (TEN) or [[Stevens-Johnson syndrome]]) to ritonavir or any of its ingredients.
*Co-administration of NORVIR with several classes of drugs (including sedative hypnotics, antiarrhythmics, or ergot alkaloid preparations) is contraindicated and may result in potentially serious and/or life-threatening adverse events due to possible effects of NORVIR on the hepatic metabolism of these drugs (see Table 1). [[Voriconazole]] and [[St. John’s Wort]] are exceptions in that co-administration of NORVIR and voriconazole results in a significant decrease in plasma concentrations of voriconazole, and co-administration of NORVIR with St. John’s Wort may result in decreased ritonavir plasma concentrations.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = NORVIR (RITONAVIR) CAPSULE [ABBVIE INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13b059c6-0c6c-49a5-b985-a4b05caf9ac9 | publisher =  | date =  | accessdate =  }}</ref>
*Co-administration of NORVIR with several classes of drugs (including sedative hypnotics, antiarrhythmics, or ergot alkaloid preparations) is contraindicated and may result in potentially serious and/or life-threatening adverse events due to possible effects of NORVIR on the hepatic metabolism of these drugs (see Table 1). [[Voriconazole]] and [[St. John’s Wort]] are exceptions in that co-administration of NORVIR and voriconazole results in a significant decrease in plasma concentrations of voriconazole, and co-administration of NORVIR with St. John’s Wort may result in decreased ritonavir plasma concentrations.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = NORVIR (RITONAVIR) CAPSULE [ABBVIE INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13b059c6-0c6c-49a5-b985-a4b05caf9ac9 | publisher =  | date =  | accessdate =  }}</ref>




Line 16: Line 16:
|-
|-
|}
|}


==References==
==References==

Latest revision as of 17:34, 9 January 2014

Ritonavir
NORVIR® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Contraindications

  • When co-administering NORVIR with other protease inhibitors, see the full prescribing information for that protease inhibitor including contraindication information.
  • NORVIR is contraindicated in patients with known hypersensitivity (e.g., toxic epidermal necrolysis (TEN) or Stevens-Johnson syndrome) to ritonavir or any of its ingredients.
  • Co-administration of NORVIR with several classes of drugs (including sedative hypnotics, antiarrhythmics, or ergot alkaloid preparations) is contraindicated and may result in potentially serious and/or life-threatening adverse events due to possible effects of NORVIR on the hepatic metabolism of these drugs (see Table 1). Voriconazole and St. John’s Wort are exceptions in that co-administration of NORVIR and voriconazole results in a significant decrease in plasma concentrations of voriconazole, and co-administration of NORVIR with St. John’s Wort may result in decreased ritonavir plasma concentrations.[1]


[[File:|800px|thumb]]

References

  1. "NORVIR (RITONAVIR) CAPSULE [ABBVIE INC.]".

Adapted from the FDA Package Insert.